UK markets closed

Alto Neuroscience, Inc. (ANRO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
13.84-0.32 (-2.26%)
As of 02:57PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
0
210
Operating expenses
Research development
30,291
30,291
23,688
8,370
Selling general and administrative
7,518
7,518
5,504
3,896
Total operating expenses
37,809
37,809
27,455
9,292
Operating income or loss
-37,809
-37,809
-27,455
-9,082
Interest expense
1,370
1,370
0
-
Total other income/expenses net
525
525
-369
-107
Income before tax
-36,305
-36,305
-27,710
-9,187
Income from continuing operations
-36,305
-36,305
-27,710
-9,187
Net income
-36,305
-36,305
-27,710
-9,187
Net income available to common shareholders
-36,305
-36,305
-27,710
-9,187
Basic EPS
-1.28
-
-2.13
-0.94
Diluted EPS
-1.28
-
-2.13
-0.94
Basic average shares
25,574
-
12,980
9,731
Diluted average shares
25,574
-
12,980
9,731